139 related articles for article (PubMed ID: 8564519)
1. Zonal differences in nitric oxide synthesis by bovine chondrocytes exposed to interleukin-1.
Fukuda K; Kumano F; Takayama M; Saito M; Otani K; Tanaka S
Inflamm Res; 1995 Oct; 44(10):434-7. PubMed ID: 8564519
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis.
Studer RK; Georgescu HI; Miller LA; Evans CH
Arthritis Rheum; 1999 Feb; 42(2):248-57. PubMed ID: 10025918
[TBL] [Abstract][Full Text] [Related]
3. Modulation of chondrocyte proteoglycan synthesis by endogeneously produced nitric oxide.
Stefanovic-Racic M; Taskiran D; Georgescu HI; Evans CH
Inflamm Res; 1995 Aug; 44 Suppl 2():S216-7. PubMed ID: 8548407
[No Abstract] [Full Text] [Related]
4. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine.
Badger AM; Cook MN; Swift BA; Newman-Tarr TM; Gowen M; Lark M
J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture.
Häuselmann HJ; Oppliger L; Michel BA; Stefanovic-Racic M; Evans CH
FEBS Lett; 1994 Oct; 352(3):361-4. PubMed ID: 7926002
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide inhibits chondrocyte response to IGF-I: inhibition of IGF-IRbeta tyrosine phosphorylation.
Studer RK; Levicoff E; Georgescu H; Miller L; Jaffurs D; Evans CH
Am J Physiol Cell Physiol; 2000 Oct; 279(4):C961-9. PubMed ID: 11003576
[TBL] [Abstract][Full Text] [Related]
7. Concurrent generation of nitric oxide and superoxide inhibits proteoglycan synthesis in bovine articular chondrocytes: involvement of peroxynitrite.
Oh M; Fukuda K; Asada S; Yasuda Y; Tanaka S
J Rheumatol; 1998 Nov; 25(11):2169-74. PubMed ID: 9818660
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures.
Badger AM; Roshak AK; Cook MN; Newman-Tarr TM; Swift BA; Carlson K; Connor JR; Lee JC; Gowen M; Lark MW; Kumar S
Osteoarthritis Cartilage; 2000 Nov; 8(6):434-43. PubMed ID: 11069728
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide (NO) and cartilage metabolism: NO effects are modulated by superoxide in response to IL-1.
Jouzeau JY; Pacquelet S; Boileau C; Nedelec E; Presle N; Netter P; Terlain B
Biorheology; 2002; 39(1-2):201-14. PubMed ID: 12082283
[TBL] [Abstract][Full Text] [Related]
10. Degradation of bovine cartilage proteoglycan in vitro is enhanced by inhibition of nitric oxide synthase.
Hanglow AC; Rowan K; Lusch L; Coffey JW
Inflamm Res; 1995 Aug; 44 Suppl 2():S151-2. PubMed ID: 8548373
[No Abstract] [Full Text] [Related]
11. SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes.
Badger AM; Cook MN; Lark MW; Newman-Tarr TM; Swift BA; Nelson AH; Barone FC; Kumar S
J Immunol; 1998 Jul; 161(1):467-73. PubMed ID: 9647257
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1.
Taskiran D; Stefanovic-Racic M; Georgescu H; Evans C
Biochem Biophys Res Commun; 1994 Apr; 200(1):142-8. PubMed ID: 7513156
[TBL] [Abstract][Full Text] [Related]
13. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities.
Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B
Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389
[TBL] [Abstract][Full Text] [Related]
14. Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases.
Häuselmann HJ; Stefanovic-Racic M; Michel BA; Evans CH
J Immunol; 1998 Feb; 160(3):1444-8. PubMed ID: 9570565
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide production by superficial and deep articular chondrocytes.
Hayashi T; Abe E; Yamate T; Taguchi Y; Jasin HE
Arthritis Rheum; 1997 Feb; 40(2):261-9. PubMed ID: 9041937
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor alpha stimulates nitric oxide production more potently than interleukin-1beta in porcine articular chondrocytes.
Goodstone NJ; Hardingham TE
Rheumatology (Oxford); 2002 Aug; 41(8):883-91. PubMed ID: 12154205
[TBL] [Abstract][Full Text] [Related]
17. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures.
Stefanovic-Racic M; Morales TI; Taskiran D; McIntyre LA; Evans CH
J Immunol; 1996 Feb; 156(3):1213-20. PubMed ID: 8558000
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and proteoglycan turnover in rabbit articular cartilage.
Stefanovic-Racic M; Möllers MO; Miller LA; Evans CH
J Orthop Res; 1997 May; 15(3):442-9. PubMed ID: 9246092
[TBL] [Abstract][Full Text] [Related]
19. Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis.
Van de Loo FA; Arntz OJ; Van den Berg WB
Cytokine; 1997 Jul; 9(7):453-62. PubMed ID: 9237807
[TBL] [Abstract][Full Text] [Related]
20. Interaction of strain and interleukin-1 in articular cartilage: effects on proteoglycan synthesis in chondrocytes.
Gassner RJ; Buckley MJ; Studer RK; Evans CH; Agarwal S
Int J Oral Maxillofac Surg; 2000 Oct; 29(5):389-94. PubMed ID: 11071247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
